Robotic-assisted surgical systems provider Intuitive Surgical (ISRG) reported strong fourth-quarter results that exceeded analysts’ estimates. The company’s performance was aided by higher demand for its da Vinci surgical systems, which allow surgeons to perform complex procedures with better precision and control. Despite positive results, shares of the company declined 2.4% in yesterday’s after-hours trading session.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
ISRG’s Revenue and Earnings Climb Year-Over-Year
During the reported quarter, revenue climbed 25% year-over-year to $2.41 billion, surpassing the consensus estimate of $2.25 billion. The upside was driven by an 18% increase in procedures performed using its da Vinci surgical system. Moreover, ISRG placed 493 da Vinci systems in the quarter, reflecting its strong demand.
In addition, adjusted earnings per share came in at $2.21, surpassing the analysts’ expectations of $1.79. Also, the reported figure increased by 38.1% from the year-ago quarter.
ISRG Provides 2025 Outlook
For 2025, Intuitive Surgical has guided for 13% to 16% procedure growth. However, the guidance lags behind the 17% growth achieved in 2024.
Further, adjusted gross profit margin is expected to decline by 1% to 2%, with potential impacts from new tariffs.
Is Intuitive Surgical a Buy or Sell?
Turning to Wall Street, ISRG stock has a Strong Buy consensus rating based on 11 Buys and three Holds assigned in the last three months. At $611.50, the average Intuitive Surgical price target implies a 0.47% upside potential. Shares of the company have gained 34% over the past six months.
